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ABSTRACT
MicroRNAs (miRNAs) bind to Argonaute proteins,
and together they form the RISC complex and
regulate target mRNA translation and/or stability.
Identification of mRNA targets is key to deciphering
the physiological functions and mode of action
of miRNAs. In mammals, miRNAs are generally
poorly homologous to their target sequence, and
target identification cannot be based solely on
bioinformatics. Here, we describe a biochemical
approach, based on tandem affinity purification, in
which mRNA/miRNA complexes are sequentially
pulled down, first via the Argonaute moiety and
then via the miRNA. Our ‘TAP-Tar’ procedure
allows the specific pull down of mRNA targets of
miRNA. It is useful for validation of targets predicted
in silico, and, potentially, for discovery of previously
uncharacterized targets.
INTRODUCTION
MicroRNAs (miRNAs) are short (20–24nt) non-coding
RNAs transcribed from intergenic or intronic sequences
as long precursors that are sequentially processed by
the endonucleases Drosha and Dicer into short
double-stranded sequences (1–3). They regulate gene
expression at the post-transcriptional level: in the cyto-
plasm, miRNAs guide a complex of proteins that
includes a member of the Argonaute family, together
with which they form the RISC complex, toward a
target messenger RNA (1–4). Dependent on the degree
of homology between the target and the small RNA, the
RISC complex will either cleave the target messenger or
inhibit its translation (5,6).
MiRNAs are important gene regulators, both during
development and in adults (7). Unraveling their mode of
action and the cell pathways they control requires the
identiﬁcation of their mRNA targets. In mammals,
miRNAs are in most cases poorly homologous to their tar-
gets. Various algorithms exist for prediction of miRNA
targets, based on the ‘seed’, a sequence of 7–8nt at the
50 of the miRNA (from 2 to 10nt) that is generally
completely homologous to the target (4). Prediction
programs are continually being optimized, and the most
recent versions of these programs predict a high number of
targets for each miRNA, several hundreds in many cases
(4,8). These, however, are only predictions that need to be
validated experimentally. Validation is generally based on
reporter assays, in which the predicted miRNA target
sequence is inserted into the 30 UTR of the reporter
gene, thereby conferring sensitivity to the miRNA (9).
This reporter assay proves that a given mRNA is poten-
tially a target for a miRNA. However, to directly prove
the mRNA/miRNA interaction and its physiological
relevance, an assay demonstrating that the mRNA is
physically bound to the miRNA inside cells is needed.
Biochemical approaches have been designed to address
this issue. In some cases, the Argonaute-containing
complexes are pulled down, and associated miRNAs and
mRNAs are identiﬁed using various procedures (10–12).
Associated mRNAs are then subjected to in silico searches
for the seed sequences of associated miRNAs. This
approach limits the identiﬁcation of targets to those con-
taining a perfect or near-perfect seed match, which may or
may not be the case in vivo (4,5,13–15). Another approach
uses the miRNA as a primer for target mRNA ampliﬁca-
tion by qRT-PCR, but this has been reported only for
C. elegans (16).
Another series of studies has attempted to pull down
mRNAs speciﬁcally associated with a miRNA of
interest. These biochemical assays are based on the intro-
duction of biotinylated synthetic miRNAs into cells,
followed by a pull-down on streptavidin beads (17). This
technology has helped identify new targets for miRNAs
(15,18), but its application remains limited. Indeed,
one-step procedures for pull down are generally prone to
high levels of background. Here, in order to circumvent
this major concern, we developed a two-step procedure
(Figure 1), in which the mRNA/miRNA complex is ﬁrst
pulled down with anti-FLAG antibodies and then puriﬁed
on streptavidin beads. This procedure greatly reduced
the background and allowed us to demonstrate
unambiguously a physical association between miR-20a
and its mRNA target E2F-1. Our Tandem Aﬃnity
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provides an assay for direct validation of target mRNAs.
MATERIALS AND METHODS
Cell culture and transfection
HeLa S3 (XLP) cells were cultured with Dulbecco’s
modiﬁed Eagle’s medium (Invitrogen) containing 10%
foetal calf serum. The HeLa S3 cell lines stably expressing
Flag-HA-AGO1 and Flag-HA-AGO2 were obtained
using retroviral vectors as previously described (19). A
cell line transduced with the empty pREV vector was
used as a control.
Synthetic miRNAs (15nM) were transfected into cells
using HiPerfect (Qiagen) according to the manufacturer’s
instructions. Synthetic miRNA sequences were: (i)
miR20a strand: UAAAGUGCUUAUAGUGCAGGUA
G; (ii) miR20a* strand: ACUGCAUUAUGAGCACUU
AAAGU; (iii) miR125b1 strand: UCCCUGAGACCCUA
ACUUGUGA; and (iv) miR125b1* strand: ACGGGUU
AGGCUCUUGGGAGCU. Synthetic miRNAs were
biotinylated at the 30-end with a C10O4 spacer (purchased
from Sigma-Aldrich). No other spacer was tested.
Coupling the biotin to the 50-end impaired miRNA eﬃ-
ciency (data not shown), and no other coupling site was
tested.
Western blot
Cells were harvested 3 days after transfection and lysed
using 300mM NaCl, 50mM Tris pH 7.5, 0.4% NP40 and
10mM MgCl2. Alternatively, for TAP-Tar analysis,
equivalent volumes of lysate or eluate were diluted in
20mM Tris pH 8. Migration, transfer and staining were
performed using standard procedures. Antibodies used
were: mouse anti-HA, clone HA-7, Sigma, 1:1000;
mouse anti-E2F1, KH95, Santa Cruz Biotechnology,
1:500; mouse anti-b-actin, clone AC-15, Sigma, 1:1000;
peroxydase-anti-mouse Fab, A9917, Sigma, 1:5000.
qRT-PCR
For qRT-PCR, RNA was extracted using TRI reagent
(Euromedex). When RNA levels were low RNA was
puriﬁed using nucleospin RNA XS kits
(Macherey-Nagel). In some cases, qRT-PCRs were per-
formed directly on eluates, without prior RNA extraction;
this procedure did not modify PCR eﬃciency (data not
shown). One-step qRT-PCRs were performed using the
QuantiTect SYBR Green RT-PCR kit (Qiagen) as recom-
mended by the manufacturer on a LightCycler (Roche).
Analyses were performed as advised by Roche. Primers
used were as follows: cyclophilin A forward, GTCAAC
CCCACCGTGTTCTT; cyclophilin A reverse, CTGCTG
TCTTTGGGACCTTGT; E2F1, commercially available
Hs_E2F1_1_SG QuantiTect primer assay (Qiagen).
TAP-Tar
Cells were transfected with biotinylated miRNA (15nM)
as described above; the medium was replaced with fresh
medium 6h afterwards, and cells were harvested 2h later.
Cells were lysed at  80 C for 1hin 10% glycerol, 20mM
Tris (pH 8), 0.2mM EDTA, 0.5% NP-40, 0.5M KCl,
1mM DTT, supplemented with 2 protease inhibitor
(Roche) and 1u/ml RNAse OUT (Invitrogen) (volume to
volume with the cell pellet).
Extracts were submitted to sequential aﬃnity puriﬁca-
tion, ﬁrst using anti-Flag M2 agarose beads (A2220,
Sigma; 20ml for 100ml of cell extract) followed by
washes and elution with 1mg/ml Flag peptide (sequence
DYKDDDDK) in 10% glycerol, 20mM Tris (pH 8),
0.2mM EDTA, 0.5% NP-40, 0.1M KCl, 1mM DTT,
and then complexed on M280 magnetic streptavidin
beads (Invitrogen; 100ml of beads for 50ml of Flag
eluate, concentration of beads adjusted to 10mg/ml) in
the same buﬀer. Streptavidin beads were washed 6 times
with 10% glycerol, 20mM Tris (pH 8), 0.2mM EDTA,
0.5%NP-40, 0.35M KCl, 1mM DTT, and bound
complexes were eluted in high salt—25mM Tris HCl
pH 7.4, 1mM EDTA, 1M KCl, 10% glycerol, 1mM
DTT, 2 protease inhibitor (Roche) 1u/ml RNAse OUT
(Invitrogen). In some experiments, RNA was directly
extracted from the beads without elution, using the RA1
reagent from the nucleospin RNA XS kit (Macherey–
Nagel). Proteins were directly extracted in 4 NuPAGE
LDS sample buﬀer.
RESULTS AND DISCUSSION
Mir-20a was used to set up the assay, because both
mir-20a and its previously validated target E2F1 (20) are
expressed in HeLa cells (Figure 2), even though E2F1 is a
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Figure 1. Strategy for mRNA/miRNA pull-down. Extracts from cells
expressing a tagged version of Argonaute protein and transfected with
biotinylated miRNA are ﬁrst immunoprecipitated using anti-FLAG
antibodies, and then aﬃnity puriﬁed on streptavidin beads. mRNAs
are quantiﬁed by qRT-PCR.
e20 Nucleic Acids Research, 2010,Vol. 38,No. 4 PAGE 2 OF 5low-abundance mRNA. The HeLa-derived cell line
expressing a tagged version of AGO1 was transfected
with biotinylated miR-20a or with biotinylated
miR-125b as a negative control. Direct quantiﬁcation of
the miRNA by qRT-PCR showed a vast excess of the
ectopic miRNA over the endogenous species (Figure 2A
for miR-20a, data not shown for miR-125b). Ectopic
biotinylated miR-20a miRNA was active, as it was able
to down-regulate the previously characterized target
protein E2F1 (Figure 2B). Moreover, a small decay of
E2F1 mRNA was also reproducibly observed in
miR-20a-transfected cells (Figure 2C), as previously
shown for other miRNA targets (8,21–24).
We ﬁrst conﬁrmed the association between the
transfected miRNA and the Argonaute 1 protein
complex. AGO1-transduced cells were transfected with
biotinylated miR-20a, or biotinylated miR-125b as a
control, and cell extracts analyzed after pull down with
anti-FLAG followed by streptavidin. Around 2% of
total AGO1 protein was pulled down using this procedure
with both miRNAs (Figure 3). Maximum association, as
judged after a one-step procedure on streptavidin beads,
was observed as early as 8h after transfection
(Supplementary Figure S1, upper panel), similar to what
was observed by Ohrt et al. (25). The association between
biotinylated miR-20a and AGO1 slightly decreased there-
after, but remained detectable at least up to 48h after
transfection. AGO1 was not pulled down in the absence
of biotinylated miRNA. Similar results were obtained
with Flag-HA AGO2, although the percentage of
precipitated complex was lower and a higher background
was consistently observed (Supplementary Figure S1,
lower panel). These results demonstrate a rapid and
speciﬁc physical association between the FLAG-HA
tagged Argonaute proteins and the biotinylated miRNA.
The diﬀerence between AGO1 and AGO2 could be
explained by a diﬀerential incorporation of miR-20a in
AGO1 versus AGO2 complex. Alternatively, it could be
due to the higher level of expression of Flag-AGO2
compared with Flag-AGO1 (data not shown).
We next compared the eﬃciency of the tandem aﬃnity
puriﬁcation procedure with that of the previously pub-
lished one-step technology for target enrichment.
Extracts from cells transfected with biotinylated
miRNAs were submitted to sequential aﬃnity puriﬁcation
as described in Figure 1 or to a simple pull-down with
streptavidin. E2F1 mRNA and Cyclophilin A mRNA, a
highly expressed housekeeping gene used as a control,
were quantiﬁed using qRT-PCR. Precipitation of the com-
plex via the miRNA with streptavidin resulted in a signif-
icant enrichment of E2F1 target (Figure 4A, Strep.).
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Figure 2. Biotinylated miR-20a is expressed and active.
Flag-HA-AGO1 cells were transfected with biotinylated miR-20a,
miR-125b or an irrelevant sequence (ir.) as indicated. (A) Levels of
miR-20a were quantiﬁed using qRT-PCR (Log scale); representative
of two independent experiments. (B) E2F-1 protein, a previously
characterized miR-20a target (20), monitored by western blot 3 days
after transfection; representative of 3 independent experiments. (C)
E2F-1 mRNA monitored by qRT-PCR. Standard deviation is from
10 independent experiments. ***P<0.001.
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Figure 3. Interaction between biotinylated miR-20a and AGO proteins. Extracts of cells expressing tagged AGO1, and transfected with miR-20a or
miR-125b as indicated, were immunoprecipitated with anti-Flag (a-Flag) followed by streptavidin (a-Flag+strep.) and analyzed by western blot with
anti-HA antibodies; the ﬁnal wash (wash) was also analyzed.
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biotinylated miR-125b, an irrelevant miRNA for which
no similarity with E2F1 was found (http://www.
targetscan.org/cgi-bin/vert_50/view_genetable.cgi?gs=E
2F1&taxid=9606&members=miR-17-5p/20/93.mr/106/
519.d&showcnc=1&shownc=1). Thus, this procedure is
not optimal with regard to speciﬁcity. Indeed, one-step
puriﬁcation procedures are usually less speciﬁc than
two-step protocols, each step providing enrichment and
decreasing background. Moreover, endogenous biotiny-
lated proteins, as well as free biotinylated miR-20a not
incorporated into the RISC complex, are present in the
total lysates and may bind to the streptavidin beads if not
previously eliminated, competing with loading of RISC
complexes. To overcome this problem, the complex
was ﬁrst puriﬁed via the Argonaute protein prior to pre-
cipitation via the biotinylated miR-20a miRNA moiety,
thus reducing contaminants. Using this protocol,
E2F1 mRNA enrichment using AGO1 protein
(Figure 4A, a-F+strep) or AGO2 protein (data not
shown) was greater. Most importantly, this enrichment
was restricted to miR-20a, for which the ratio
E2F1mRNA:Cyclophilin A mRNA was increased by
15-fold as compared with the input, whereas such an
enrichment was not observed with miR-125b, even
though the two miRNAs were both bound to Argonaute
proteins (Figure 3). Similar results were obtained with
Flag-HA-AGO1 and Flag-HA-AGO2 (Figure 4B).
However, enrichment was slightly less pronounced with
AGO2, possibly due to the target mRNA cleaving
activity of AGO2 (26) that impairs detection of the
mRNA by RT-PCR. In any case, the procedure was
more eﬃcient with AGO1, and we thus focused on
AGO1 complex.
The biochemical yield of each step was in the expected
range, as judged from the recovery of AGO1 proteins
( 50% after Flag immunoprecipitation, and 2% after
streptavidin—ﬁnal yield). The recovery of E2F1 mRNA
was much lower (0.7% after Flag, and 0.4% after
streptavidin, with a ﬁnal yield of 0.01%). The low yield
of the second step is partly due to the high avidity of biotin
for streptavidin, which impairs elution; indeed, direct
extraction of E2F1 resulted in much better recovery with
a 4% yield. However, the diﬀerence between Argonaute
protein recovery and E2F1 mRNA recovery most likely
reﬂects a low proportion of E2F1 mRNA bound to the
RISC complex in these cells. Thus, even with a low abun-
dance mRNA, poorly bound to RISC, the procedure
allowed us to validate the interaction between the
miRNA and the mRNA.
The results with AGO1 were highly reproducible, as
shown in the compilation of 10 experiments (Figure 4C).
The association to the target mRNA was, at least for
the most part, formed in cells, since the addition of
biotinylated miR20a to cell extracts did not result in a
pull-down of mRNA quantitatively as pronounced
as that observed in transfected cells (Supplementary
Figure S2).
Taken together, these results show that our tandem
aﬃnity procedure for mRNA target validation
(TAP-Tar) is speciﬁc, robust, and provides a mean for
2
4
6
8
10
12
14
16
18
r
a
t
i
o
 
E
2
F
 
m
R
N
A
/
C
y
c
 
A
 
m
R
N
A
 
(
x
 
1
0
-
2
)
20a
125b
E2F1
CycA
I a-F Strep.
a-F
+
Strep.
A
C
B
m
R
N
A
 
2
0
a
 
/
 
m
R
N
A
 
1
2
5
b
E2F1
CycA
I a-F
a-F
+
Strep.
I a-F
a-F
+
Strep.
AGO1 AGO2
0
1
2
3
4
5
6
0
2
4
6
8
10
12
m
R
N
A
 
2
0
a
 
/
 
m
R
N
A
 
1
2
5
b
I a-F
a-F
+
Strep.
***
Figure 4. E2F1 mRNA is enriched in miR-20a complexes. (A) Extracts
of cells expressing tagged AGO1 and transfected with biotinylated
miR-20a or miR-125b as indicated, were submitted to aﬃnity puriﬁca-
tion on streptavidin beads (Strep.), to immunoprecipitation with
anti-Flag antibodies (a-F) or to tandem aﬃnity puriﬁcation
(a-F+Strep.). E2F1 and Cyclophilin A mRNAs were quantiﬁed
using qRT-PCR; results are presented as the ratio between E2F1 and
Cyclophilin A mRNAs; representative of two experiments. (B)A si nA
except that cells expressed either AGO1 or AGO2 as indicated; results
are presented as the ratio between miR-20a and miR-125b pull-downs
for each mRNA, as indicated; representative of 10 independent
experiments for AGO1 and 2 independent experiments for AGO2.
(C) Extracts of cells expressing tagged AGO1 and transfected with
biotinylated miR-20a or miR-125b, as indicated, were submitted to
aﬃnity puriﬁcation on streptavidin beads (Strep.), to immunopre-
cipitation with anti-Flag antibodies (a-F) or to tandem aﬃnity puriﬁ-
cation (a-F+Strep.). E2F1 and Cyclophilin A mRNAs were quantiﬁed
using qRT-PCR; results are presented as the ratio between miR-20a
and miR-125b pull-downs for each mRNA, as indicated; mean of
10 totally independent experiments; results are presented as the ratio
between miR-20a and miR-125b pull-downs for each mRNA. The
diﬀerence was signiﬁcant. ***P<0.001.
e20 Nucleic Acids Research, 2010,Vol. 38,No. 4 PAGE 4 OF 5direct target validation in cells. The major drawback of
this approach is that test cells need to be transfected,
similar to the standard reporter assay generally used to
validate miRNA targets. Our assay, however, has the
advantage of demonstrating a physical interaction
between the target and the miRNA in a RISC complex,
even though both Argonaute and the miRNA are of
exogenous origin in these experiments. Moreover,
provided that a transfectable cell can be used, our
unbiased approach might be useful to discover previously
uncharacterized new targets. Indeed, mRNAs that are
pulled down using TAP-Tar can be globally analyzed
using standard mRNA detection assays (arrays or deep
sequencing). Coupled to bioinformatics analysis of the
hits, similar to what has been done in several published
studies (10–12,15,18), such a procedure might help to
discover unpredicted targets and, ultimately, lead to
reﬁnement of target prediction programs.
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